Pureに変更を加えた場合、すぐここに表示されます。

Fingerprint Yasuo Hamamotoが取り組む研究トピックをご確認ください。これらのトピックラベルは、この人物の研究に基づいています。これらを共に使用することで、固有の認識が可能になります。

  • 48 同様のプロファイル
irinotecan Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

ネットワーク 最近の共同研究。丸をクリックして詳細を確認しましょう。

研究成果 1998 2020

  • 3792 引用
  • 26 h指数
  • 89 Article
  • 5 Review article
  • 3 Letter
  • 2 Comment/debate
1 引用 (Scopus)

A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer

Yokota, T., Kato, K., Hamamoto, Y., Tsubosa, Y., Ogawa, H., Ito, Y., Hara, H., Ura, T., Kojima, T., Chin, K., Hironaka, S., Kii, T., Kojima, Y., Akutsu, Y., Matsushita, H., Kawakami, K., Mori, K., Makiuchi, T., Nagumo, R. & Kitagawa, Y., 2020 2 1, : : Annals of Surgical Oncology. 27, 2, p. 460-467 8 p.

研究成果: Article

Esophageal Neoplasms
Disease-Free Survival
Induction Chemotherapy
Survival
docetaxel

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

Chen, L. T., Satoh, T., Ryu, M. H., Chao, Y., Kato, K., Chung, H. C., Chen, J. S., Muro, K., Kang, W. K., Yeh, K. H., Yoshikawa, T., Oh, S. C., Bai, L. Y., Tamura, T., Lee, K. W., Hamamoto, Y., Kim, J. G., Chin, K., Oh, D. Y., Minashi, K. および5人, Cho, J. Y., Tsuda, M., Sameshima, H., Kang, Y. K. & Boku, N., 2019 1 1, (Accepted/In press) : : Gastric Cancer.

研究成果: Article

公開
Esophagogastric Junction
Stomach
Survival
Neoplasms
Placebos

A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure–Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial)

Suzuki, T., Sukawa, Y., Imamura, C. K., Masuishi, T., Satake, H., Kumekawa, Y., Funakoshi, S., Kotaka, M., Horie, Y., Kawai, S., Okuda, H., Terazawa, T., Kondoh, C., Kato, K., Yoshimura, K., Ishikawa, H., Hamamoto, Y., Boku, N., Takaishi, H. & Kanai, T., 2019 1 1, (Accepted/In press) : : Clinical Colorectal Cancer.

研究成果: Article

Colorectal Neoplasms
regorafenib
4 引用 (Scopus)

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

Kato, K., Satoh, T., Muro, K., Yoshikawa, T., Tamura, T., Hamamoto, Y., Chin, K., Minashi, K., Tsuda, M., Yamaguchi, K., Machida, N., Esaki, T., Goto, M., Komatsu, Y., Nakajima, T. E., Sugimoto, N., Yoshida, K., Oki, E., Nishina, T., Tsuji, A. および11人, Fujii, H., Kunieda, K., Saitoh, S., Omuro, Y., Azuma, M., Iwamoto, Y., Taku, K., Fushida, S., Chen, L. T., Kang, Y. K. & Boku, N., 2019 3 15, : : Gastric Cancer. 22, 2, p. 344-354 11 p.

研究成果: Article

公開
Esophageal Neoplasms
Stomach
Placebos
Drug Therapy
Survival
1 引用 (Scopus)

Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial

Yoshikawa, T., Muro, K., Shitara, K., Oh, D. Y., Kang, Y. K., Chung, H. C., Kudo, T., Chin, K., Kadowaki, S., Hamamoto, Y., Hironaka, S., Yoshida, K., Yen, C. J., Omuro, Y., Bai, L. Y., Maeda, K., Ozeki, A., Yoshikawa, R. & Kitagawa, Y., 2019 8 2, : : JAMA network open. 2, 8, p. e198243

研究成果: Article

公開
oxaliplatin
Far East
Paclitaxel
Stomach Neoplasms
Randomized Controlled Trials